Search results for "Niacin"

showing 9 items of 89 documents

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond.

2018

The hepatocellular carcinoma (HCC) treatment landscape changed a decade ago, with sorafenib demonstrating survival benefit in the first-line setting and becoming the first systemic therapy to be approved for HCC. More recently, regorafenib and nivolumab have received approval in the second-line setting after sorafenib, with further positive phase 3 studies emerging in the first line (lenvatinib non-inferior to sorafenib) and second line versus placebo (cabozantinib and ramucirumab). A key recommendation in the management of patients receiving sorafenib is to promote close communication between the patient and the physician so that adverse events (AEs) are detected early and severe AEs can b…

SorafenibOncologyNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularCabozantinibAntineoplastic Agentsurologic and male genital diseasesRamucirumab03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineRegorafenibmedicineHumansheterocyclic compoundsRadiology Nuclear Medicine and imagingAdverse effectneoplasmsProtein Kinase InhibitorsRandomized Controlled Trials as TopicClinical Trials as Topicbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral MedicineSorafenibmedicine.diseasefemale genital diseases and pregnancy complicationsdigestive system diseasesOncologychemistry030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyNivolumabLenvatinibbusinessmedicine.drugCancer treatment reviews
researchProduct

Immune oncology in hepatocellular carcinoma-hype and hope.

2017

SorafenibOncologyNiacinamidemedicine.medical_specialtyCarcinoma HepatocellularPyridinesMEDLINEAntineoplastic AgentsDrug resistance03 medical and health sciences0302 clinical medicineImmune systemInternal medicinemedicineCarcinomaNeoplasmHumans030212 general & internal medicineProtein Kinase Inhibitorsbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral MedicineSorafenibmedicine.diseaseDrug Resistance NeoplasmHepatocellular carcinoma030211 gastroenterology & hepatologybusinessmedicine.drugLancet (London, England)
researchProduct

Coupled variable selection for regression modeling of complex treatment patterns in a clinical cancer registry.

2013

For determining a manageable set of covariates potentially influential with respect to a time-to-event endpoint, Cox proportional hazards models can be combined with variable selection techniques, such as stepwise forward selection or backward elimination based on p-values, or regularized regression techniques such as component-wise boosting. Cox regression models have also been adapted for dealing with more complex event patterns, for example, for competing risks settings with separate, cause-specific hazard models for each event type, or for determining the prognostic effect pattern of a variable over different landmark times, with one conditional survival model for each landmark. Motivat…

Statistics and ProbabilityMaleNiacinamideBoosting (machine learning)Carcinoma HepatocellularEpidemiologyComputer scienceScoreFeature selectionAntineoplastic Agentscomputer.software_genreDecision Support TechniquesNeoplasmsCovariateHumansRegistriesAgedProportional Hazards ModelsProportional hazards modelPhenylurea CompoundsLiver NeoplasmsRegression analysisConfounding Factors EpidemiologicMiddle AgedSorafenibPrognosisRegressionCancer registryData Interpretation StatisticalRegression AnalysisData miningcomputerStatistics in medicine
researchProduct

Preservation of vitamins content in Cuccìa using an innovative method of processing

2019

Cuccìa is a traditional Sicilian food prepared by boiling whole durum wheat kernels, in water, for many hours. This process destroys the vitamins E and B contents of crude kernels. It was rated a method to prepare the Cuccìa, preserving the vitamin content. Four varieties of durum wheat were processed comparing the traditional cooking method (TR-boiling for 5/6 hours), and an innovative one (IN-grains scarification, germination, and cooking at 50 °C for 2 hours). On soups obtained the content of biotin, niacin and α-amylase activity were determined. ANOVA showed the cooking method influences biotin and niacin content having values from 0.56 and 0.72 ng ml−1 (raw grain) and values close to 0…

Time FactorsBiotinPlant ScienceCuccìa processingNiacin01 natural sciencesBiochemistryAnalytical ChemistryPlant scienceBoilingold varietieVitamin ECookingTriticumold varieties010405 organic chemistryChemistryOrganic ChemistryTemperaturevitaminfood and beveragesdurum wheatvitaminsPulp and paper industry0104 chemical sciences010404 medicinal & biomolecular chemistryFoodScientific methodalpha-AmylasesEdible GrainNatural Product Research
researchProduct

J15 Validation Of 24 H Dietary Recalls To Assess Dietary Intake For Patients With Huntington's Disease. Spanish Multicenter Study Of The European Gro…

2014

Background Weighed dietary records are considered as the gold standard in nutrition assessment, but 24 h dietary recalls (24-h) and 3 days dietary record (3-d) are usually used. The 24-h is less laborious and cheaper but is necessary to have an experienced interviewer; while the 3-d are completed by the same participant/caregiver, it is more reliable but more expensive, time consuming is high, require previous training and have more dropouts. Our aim was to compare the two procedures to assess dietary intake in HD. Objectives To validate a 24-h vs 3-d to assess dietary intake for patients with HD. Methods Spanish multicenter, longitudinal study (EHDN). A 24-h was administered (with a one-mo…

Vitaminmedicine.medical_specialtyLongitudinal studybusiness.industryCholesterolConcordancefood and beveragesmedicine.diseasePyridoxineSurgeryPsychiatry and Mental healthchemistry.chemical_compoundHuntington's diseasechemistryInternal medicineEpidemiologymedicineSurgeryNeurology (clinical)businessNiacinmedicine.drugJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Assessment of Intake of Nicotinic Acid and Nicotinamide in Relation to Tolerable Upper Intake Levels

2018

chemistry.chemical_compoundNicotinic agonistNicotinamidechemistryFood supplementbusiness.industryDietary Reference IntakePhysiologyMedicinebusinessRisk assessmentNiacinEuropean Journal of Nutrition & Food Safety
researchProduct

A minireview on NHE1 inhibitors. A rediscovered hope in oncohematology.

2015

Background: Na+/H+ exchanger-1 (NHE-1) is involved in pH regulation and is up-regulated in different malignancies. Activation of NHE-1 is one way for allowing cells to avoid intracellular acidification and protect them against apoptosis. Inhibitors of NHE-1 are able to decrease intracellular pH and induce apoptosis. Some statins can also act by partial inhibition of NHE-1. This review presents progress in understanding the mechanisms of action of these inhibitors, connections with certain genetic mutations and acquired treatment resistance, as well as new patents on them. Methods: A MEDLINE search for original and review articles using key terms, Na+/H+ exchanger, leukemia, cariporide, and …

lovastatinlcsh:MedicineApoptosisPharmacologyGuanidinesAmiloridep-glycoproteinhemic and lymphatic diseasesDrug InteractionsSulfonesCation Transport ProteinsSodium-Hydrogen Exchanger 1leukemiaMyeloid leukemiaHydrogen-Ion ConcentrationSorafenibUp-RegulationLeukemiaLeukemia Myeloid AcuteImatinib MesylateSignal transductionTyrosine kinasemedicine.drugSignal TransductionSorafenibNiacinamideisoprenylationSodium-Hydrogen Exchangersbcr/ablAntineoplastic AgentsGenes ablGeneral Biochemistry Genetics and Molecular BiologystatinsPatents as TopicCell Line TumorLeukemia Myelogenous Chronic BCR-ABL PositivemedicineHumansProtein Kinase Inhibitorscariporidena+/h+ exchangerTumor hypoxiabusiness.industryPhenylurea Compoundslcsh:ROsmolar Concentrationintracellular phmedicine.diseaseImatinib mesylatefms-Like Tyrosine Kinase 3Fms-Like Tyrosine Kinase 3MutationCancer researchTumor Hypoxiaflt3/itdHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessHeme Oxygenase-1DNA DamageBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Adipokines and Lipoproteins: Modulation by Antihyperglycemic and Hypolipidemic Agents

2014

Abstract Adipose tissue is an endocrine organ that secretes a number of hormones and metabolically active substances that impact energy metabolism and insulin sensitivity. These inflammatory markers are collectively referred to as adipocytokines, or adipokines. Adipose tissue's functional capacity and metabolic activity vary among individuals, thus partly explaining the incomplete overlap between obesity and the metabolic syndrome. The functional failure of adipose tissues results in changed energy delivery and impaired glucose consumption, triggering self-regulatory mechanisms to maintain homeostasis. Antihyperglycemic, hypolipidemic, antiobesity, and angiotensin II receptor blocker drugs …

medicine.medical_specialtyLipoproteinsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAdipokineAdipose tissueIncretinsNiacinAnti-Obesity AgentsInsulin resistanceAdipokinesInternal medicineInternal MedicineAnimalsHumansHypoglycemic AgentsInsulinMedicineHypolipidemic AgentsMetabolic Syndromebusiness.industryInsulinFibric AcidsEzetimibemedicine.diseaseLipidsMetforminGlucoseEndocrinologyAdipose TissueHypolipidemic AgentsAzetidinesThiazolidinedionesAnti-Obesity AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistanceMetabolic syndromebusinessHormoneMetabolic Syndrome and Related Disorders
researchProduct

Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells

2013

Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of advanced HCC. However, although sorafenib is well tolerated, concern for its safety has been expressed. Celecoxib (Celebrex®) is a selective cyclooxygenase-2 (COX-2) inhibitor which exhibits antitumor effects in human HCC cells. The present study examined the interaction between celecoxib and sorafenib in two human liver tumor cell lines HepG2 and Huh7. Our data showed that each inhibitor alone reduced cell growth and the combination of celecoxib with sorafenib synergistically inhibited cell growth an…

medicine.medical_treatmentCancer TreatmentGene ExpressionApoptosisPharmacologyBiochemistryTargeted therapy0302 clinical medicineMolecular Cell Biology0303 health sciencesSulfonamidesMultidisciplinaryReverse Transcriptase Polymerase Chain ReactionQLiver NeoplasmsRDrug SynergismGenomicsSorafenib3. Good healthGene Expression Regulation NeoplasticOncology030220 oncology & carcinogenesisMedicineLiver cancermedicine.drugResearch ArticleBiotechnologySignal TransductionSorafenibNiacinamideProgrammed cell deathCarcinoma HepatocellularScienceBlotting WesternBiologyMolecular Genetics03 medical and health sciencesCell Line TumorGastrointestinal TumorsmedicineIn Situ Nick-End LabelingHumansneoplasmsBiology030304 developmental biologyCell ProliferationDNA PrimersHuman liver cancer Apoptosis Sorafenib Celecoxib anti-proliferative effectsCell growthGene Expression ProfilingPhenylurea CompoundsComputational BiologyCancers and NeoplasmsHepatocellular CarcinomaChemotherapy and Drug Treatmentmedicine.diseaseMicroarray Analysisdigestive system diseasesGene expression profilingApoptosisCell cultureCelecoxibPyrazolesGenome Expression AnalysisPLoS ONE
researchProduct